Looking Forward:
About 65+ general hospitals in Korea are under contract.
Monthly recurring revenue grew more than 10x year over year.
In the US, we completed a validation study of our FDA-cleared intracranial hemorrhage AI with a top US university hospital. Publication is pending.
We are also deployed at White Rock Medical Center in Texas.
Clinical studies and US regulatory submissions for our ischemic stroke and cerebral aneurysm AI. About 10 international reference sites across the US, the Middle East, and Southeast Asia this year.
Reaching 40% or more of Korean general hospitals by 2027.
Thank you to our investors and hospital partners for their trust.
https://www.newstopkorea.com/news/articleView.html?idxno=47886